AEGON ASSET MANAGEMENT UK Plc Has $30.80 Million Stake in Xylem Inc. $XYL

AEGON ASSET MANAGEMENT UK Plc reduced its position in Xylem Inc. (NYSE:XYL) by 40.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 257,702 shares of the industrial products company’s stock after selling 175,168 shares during the quarter. AEGON ASSET MANAGEMENT UK Plc’s holdings in Xylem were worth $30,798,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. J. Stern & Co. LLP lifted its holdings in shares of Xylem by 12,326.6% during the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after acquiring an additional 45,082,435 shares during the period. Vanguard Group Inc. increased its stake in Xylem by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 30,054,743 shares of the industrial products company’s stock valued at $4,092,855,000 after acquiring an additional 152,507 shares during the period. State Street Corp increased its stake in Xylem by 2.6% in the fourth quarter. State Street Corp now owns 11,233,427 shares of the industrial products company’s stock valued at $1,529,768,000 after acquiring an additional 280,221 shares during the period. Geode Capital Management LLC raised its position in Xylem by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 6,357,278 shares of the industrial products company’s stock worth $862,364,000 after purchasing an additional 151,754 shares in the last quarter. Finally, Swedbank AB raised its position in Xylem by 6.0% in the fourth quarter. Swedbank AB now owns 5,507,966 shares of the industrial products company’s stock worth $750,075,000 after purchasing an additional 310,213 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Trading Up 0.0%

Shares of Xylem stock opened at $111.44 on Friday. Xylem Inc. has a 12-month low of $105.29 and a 12-month high of $154.27. The stock has a market capitalization of $26.49 billion, a P/E ratio of 27.72, a price-to-earnings-growth ratio of 1.59 and a beta of 1.04. The company has a 50-day simple moving average of $114.53 and a 200 day simple moving average of $126.30. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The business had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.11 billion. During the same period in the prior year, the company earned $1.03 EPS. Xylem’s revenue for the quarter was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Research analysts expect that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem announced that its Board of Directors has authorized a share repurchase plan on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s board of directors believes its stock is undervalued.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th will be paid a $0.43 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. Xylem’s payout ratio is currently 42.79%.

Insider Buying and Selling at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Jerome A. Peribere bought 1,210 shares of the company’s stock in a transaction on Monday, May 4th. The stock was bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the purchase, the director owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.32% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. JPMorgan Chase & Co. decreased their price objective on Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Weiss Ratings cut Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Stifel Nicolaus cut their target price on Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Barclays decreased their price target on Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 29th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $130.00 price target (down from $140.00) on shares of Xylem in a research report on Tuesday, March 31st. Seven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Xylem currently has an average rating of “Moderate Buy” and an average target price of $152.77.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.